This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1975 Jul 5;2(7923):42-3.

doi: 10.1016/s0140-6736(75)92996-7.

Letter: Superoxide dismutase in Down syndrome

R R Frants, A W Eriksson, P H Jongbloet, A J Hamers

PMID: 49645
DOI: 10.1016/s0140-6736(75)92996-7

Letter: Superoxide dismutase in Down syndrome

R R Frants et al. Lancet. 1975.

. 1975 Jul 5;2(7923):42-3.

doi: 10.1016/s0140-6736(75)92996-7.

Authors

R R Frants, A W Eriksson, P H Jongbloet, A J Hamers

PMID: 49645
DOI: 10.1016/s0140-6736(75)92996-7

No abstract available

PubMed Disclaimer

Similar articles

The level of superoxide dismutase in erythrocytes of children with Down syndrome (trisomy G and unbalanced translocation G 21/22).
Kedziora J, Jeske J, Witas H, Bartosz G, Leyko W. Kedziora J, et al. Acta Biol Med Ger. 1977;36(5-6):779-82. Acta Biol Med Ger. 1977. PMID: 146388 No abstract available.
Dismutase activity in translocation trisomy.
Kedziora J, Bartosz G, Leyko W, Rozynkowa D. Kedziora J, et al. Lancet. 1979 Jan;1(8107):105. doi: 10.1016/s0140-6736(79)90095-3. Lancet. 1979. PMID: 84109 No abstract available.
The estimation of red cell superoxide dismutase activity by pulse radiolysis in normal and trisomic 21 subjects.
Gilles L, Ferradini C, Foos J, Pucheault J, Allard D, Sinet PM, Jerome H. Gilles L, et al. FEBS Lett. 1976 Oct 15;69(1):55-8. doi: 10.1016/0014-5793(76)80652-7. FEBS Lett. 1976. PMID: 136364 No abstract available.
[Effect of gene dose in human cells].
Annenkov GA. Annenkov GA. Tsitol Genet. 1978 Jul-Aug;12(4):362-70. Tsitol Genet. 1978. PMID: 151956 Review. Russian.
Superoxide dismutase: pharmacological developments and applications.
Omar BA, Flores SC, McCord JM. Omar BA, et al. Adv Pharmacol. 1992;23:109-61. doi: 10.1016/s1054-3589(08)60964-3. Adv Pharmacol. 1992. PMID: 1531762 Review. No abstract available.

See all similar articles

Cited by

SOD-A and chromosome 21. Conflicting findings in a familial translocation (9p24;21q214).
Leschot NJ, Slater RM, Joenje H, Becker-Bloemkolk MJ, de Nef JJ. Leschot NJ, et al. Hum Genet. 1981;57(2):220-3. doi: 10.1007/BF00282029. Hum Genet. 1981. PMID: 7228038
Enhancement of S-100 beta protein in blood of patients with Down's syndrome.
Kato K, Suzuki F, Kurobe N, Okajima K, Ogasawara N, Nagaya M, Yamanaka T. Kato K, et al. J Mol Neurosci. 1990;2(2):109-13. doi: 10.1007/BF02876918. J Mol Neurosci. 1990. PMID: 2150320
The levels of superoxide dismutase, catalase, and carbonic anhydrase in erythrocytes of patients with Down's syndrome.
Ohno H, Lizuka S, Kondo T, Yamamura K, Sekiya C, Taniguchi N. Ohno H, et al. Klin Wochenschr. 1984 Mar 15;62(6):287-8. doi: 10.1007/BF01721891. Klin Wochenschr. 1984. PMID: 6232420
Expression of chromosome 21 specific sequences in normal and Down's syndrome tissues.
Stefani L, Galt J, Palmer A, Affara N, Ferguson-Smith M, Nevin NC. Stefani L, et al. Nucleic Acids Res. 1988 Apr 11;16(7):2885-96. doi: 10.1093/nar/16.7.2885. Nucleic Acids Res. 1988. PMID: 2966929 Free PMC article.
A case of 21q--syndrome with normal SOD-1 activity.
Yamamoto Y, Ogasawara N, Gotoh A, Komiya H, Nakai H, Kuroki Y. Yamamoto Y, et al. Hum Genet. 1979 May 10;48(3):321-7. doi: 10.1007/BF00272832. Hum Genet. 1979. PMID: 468232

See all "Cited by" articles

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions